nodes	percent_of_prediction	percent_of_DWPC	metapath
Clemastine—CYP2D6—Codeine and Morphine Metabolism—ABCC2—esophageal cancer	0.0289	0.0446	CbGpPWpGaD
Clemastine—Eletriptan—CYP2A6—esophageal cancer	0.028	0.28	CrCbGaD
Clemastine—Azelastine—CYP2A6—esophageal cancer	0.0243	0.243	CrCbGaD
Clemastine—CYP2D6—Fatty Acid Omega Oxidation—ADH7—esophageal cancer	0.0228	0.0352	CbGpPWpGaD
Clemastine—Eletriptan—PTGS1—esophageal cancer	0.0214	0.214	CrCbGaD
Clemastine—CYP2D6—Fatty Acid Omega Oxidation—ADH1B—esophageal cancer	0.02	0.0309	CbGpPWpGaD
Clemastine—CYP3A4—Codeine and Morphine Metabolism—ABCC2—esophageal cancer	0.0189	0.0291	CbGpPWpGaD
Clemastine—CYP2D6—CYP2E1 reactions—CYP2A6—esophageal cancer	0.0179	0.0276	CbGpPWpGaD
Clemastine—CYP2D6—Codeine and Morphine Metabolism—ABCB1—esophageal cancer	0.0153	0.0236	CbGpPWpGaD
Clemastine—CYP3A4—Fatty Acid Omega Oxidation—ADH7—esophageal cancer	0.0149	0.023	CbGpPWpGaD
Clemastine—CYP2D6—Fatty Acid Omega Oxidation—ALDH2—esophageal cancer	0.0141	0.0218	CbGpPWpGaD
Clemastine—Chest tightness—Capecitabine—esophageal cancer	0.0133	0.0528	CcSEcCtD
Clemastine—CYP2D6—Fatty Acid Omega Oxidation—CYP2A6—esophageal cancer	0.0133	0.0205	CbGpPWpGaD
Clemastine—CYP3A4—Tryptophan metabolism—ALDH3A2—esophageal cancer	0.0131	0.0203	CbGpPWpGaD
Clemastine—CYP3A4—Fatty Acid Omega Oxidation—ADH1B—esophageal cancer	0.0131	0.0202	CbGpPWpGaD
Clemastine—CYP3A4—Irinotecan Pathway—ABCC2—esophageal cancer	0.0121	0.0186	CbGpPWpGaD
Clemastine—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I2—esophageal cancer	0.0116	0.0179	CbGpPWpGaD
Clemastine—CYP2D6—Xenobiotics—CYP2A6—esophageal cancer	0.0111	0.0171	CbGpPWpGaD
Clemastine—CYP3A4—Benzo(a)pyrene metabolism—CYP1B1—esophageal cancer	0.0111	0.0171	CbGpPWpGaD
Clemastine—CYP2D6—Tamoxifen metabolism—CYP2A6—esophageal cancer	0.0107	0.0165	CbGpPWpGaD
Clemastine—Eletriptan—ABCB1—esophageal cancer	0.0104	0.104	CrCbGaD
Clemastine—CYP3A4—Drug Induction of Bile Acid Pathway—ABCC2—esophageal cancer	0.0103	0.0159	CbGpPWpGaD
Clemastine—CYP3A4—Codeine and Morphine Metabolism—ABCB1—esophageal cancer	0.01	0.0155	CbGpPWpGaD
Clemastine—CYP3A4—Fatty Acid Omega Oxidation—ALDH2—esophageal cancer	0.00922	0.0142	CbGpPWpGaD
Clemastine—Azelastine—ABCB1—esophageal cancer	0.00904	0.0904	CrCbGaD
Clemastine—CYP3A4—Fatty Acid Omega Oxidation—CYP2A6—esophageal cancer	0.00866	0.0134	CbGpPWpGaD
Clemastine—CYP2D6—Tamoxifen metabolism—CYP1B1—esophageal cancer	0.00859	0.0133	CbGpPWpGaD
Clemastine—Wheezing—Cisplatin—esophageal cancer	0.00823	0.0326	CcSEcCtD
Clemastine—Extrasystoles—Capecitabine—esophageal cancer	0.00743	0.0294	CcSEcCtD
Clemastine—CYP3A4—Xenobiotics—CYP2A6—esophageal cancer	0.00725	0.0112	CbGpPWpGaD
Clemastine—Chest discomfort—Capecitabine—esophageal cancer	0.00706	0.028	CcSEcCtD
Clemastine—CYP3A4—Tamoxifen metabolism—CYP2A6—esophageal cancer	0.00697	0.0108	CbGpPWpGaD
Clemastine—Haemolytic anaemia—Cisplatin—esophageal cancer	0.00682	0.027	CcSEcCtD
Clemastine—Loperamide—ABCB1—esophageal cancer	0.00681	0.0681	CrCbGaD
Clemastine—Nasal congestion—Cisplatin—esophageal cancer	0.00675	0.0268	CcSEcCtD
Clemastine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—esophageal cancer	0.00665	0.0103	CbGpPWpGaD
Clemastine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—esophageal cancer	0.00665	0.0103	CbGpPWpGaD
Clemastine—CYP2D6—Melatonin metabolism and effects—CYP1B1—esophageal cancer	0.00664	0.0102	CbGpPWpGaD
Clemastine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP26A1—esophageal cancer	0.00646	0.00997	CbGpPWpGaD
Clemastine—CYP2D6—Phase 1 - Functionalization of compounds—ADH7—esophageal cancer	0.00642	0.00992	CbGpPWpGaD
Clemastine—CYP2D6—Oxidation by Cytochrome P450—CYP26A1—esophageal cancer	0.00638	0.00984	CbGpPWpGaD
Clemastine—CYP3A4—Estrogen metabolism—CYP1B1—esophageal cancer	0.00636	0.00981	CbGpPWpGaD
Clemastine—CYP3A4—Constitutive Androstane Receptor Pathway—ABCC2—esophageal cancer	0.00623	0.00961	CbGpPWpGaD
Clemastine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC2—esophageal cancer	0.00593	0.00915	CbGpPWpGaD
Clemastine—Irritability—Cisplatin—esophageal cancer	0.00587	0.0233	CcSEcCtD
Clemastine—CYP2D6—Phase 1 - Functionalization of compounds—ADH1B—esophageal cancer	0.00563	0.0087	CbGpPWpGaD
Clemastine—CYP3A4—Tamoxifen metabolism—CYP1B1—esophageal cancer	0.00562	0.00867	CbGpPWpGaD
Clemastine—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—esophageal cancer	0.00548	0.00846	CbGpPWpGaD
Clemastine—CYP2D6—Phase 1 - Functionalization of compounds—CYP26A1—esophageal cancer	0.00524	0.00808	CbGpPWpGaD
Clemastine—Sweating increased—Cisplatin—esophageal cancer	0.00518	0.0205	CcSEcCtD
Clemastine—Photosensitivity—Capecitabine—esophageal cancer	0.00517	0.0205	CcSEcCtD
Clemastine—Haemolytic anaemia—Capecitabine—esophageal cancer	0.00502	0.0199	CcSEcCtD
Clemastine—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2A6—esophageal cancer	0.00498	0.00768	CbGpPWpGaD
Clemastine—Neuropathy peripheral—Cisplatin—esophageal cancer	0.00465	0.0184	CcSEcCtD
Clemastine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2A6—esophageal cancer	0.0046	0.00711	CbGpPWpGaD
Clemastine—CYP2D6—Oxidation by Cytochrome P450—CYP2A6—esophageal cancer	0.00454	0.00701	CbGpPWpGaD
Clemastine—Diplopia—Capecitabine—esophageal cancer	0.00454	0.018	CcSEcCtD
Clemastine—Irritability—Capecitabine—esophageal cancer	0.00433	0.0172	CcSEcCtD
Clemastine—Urinary retention—Capecitabine—esophageal cancer	0.00431	0.0171	CcSEcCtD
Clemastine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP26A1—esophageal cancer	0.00422	0.00652	CbGpPWpGaD
Clemastine—CYP3A4—Phase 1 - Functionalization of compounds—ADH7—esophageal cancer	0.0042	0.00648	CbGpPWpGaD
Clemastine—CYP3A4—Oxidation by Cytochrome P450—CYP26A1—esophageal cancer	0.00417	0.00643	CbGpPWpGaD
Clemastine—CYP2D6—Phase 1 - Functionalization of compounds—ALDH2—esophageal cancer	0.00397	0.00613	CbGpPWpGaD
Clemastine—Tinnitus—Cisplatin—esophageal cancer	0.00397	0.0157	CcSEcCtD
Clemastine—CYP3A4—Tryptophan metabolism—ALDH2—esophageal cancer	0.00396	0.00611	CbGpPWpGaD
Clemastine—Photosensitivity—Methotrexate—esophageal cancer	0.00385	0.0152	CcSEcCtD
Clemastine—Sweating increased—Capecitabine—esophageal cancer	0.00382	0.0151	CcSEcCtD
Clemastine—CYP2D6—Phase 1 - Functionalization of compounds—CYP2A6—esophageal cancer	0.00373	0.00576	CbGpPWpGaD
Clemastine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1B1—esophageal cancer	0.00371	0.00573	CbGpPWpGaD
Clemastine—CYP3A4—Phase 1 - Functionalization of compounds—ADH1B—esophageal cancer	0.00368	0.00569	CbGpPWpGaD
Clemastine—CYP2D6—Oxidation by Cytochrome P450—CYP1B1—esophageal cancer	0.00366	0.00565	CbGpPWpGaD
Clemastine—Photosensitivity reaction—Capecitabine—esophageal cancer	0.00358	0.0142	CcSEcCtD
Clemastine—HRH1—G alpha (q) signalling events—GNG7—esophageal cancer	0.00354	0.00547	CbGpPWpGaD
Clemastine—CYP2D6—Phase 1 - Functionalization of compounds—PTGS1—esophageal cancer	0.00354	0.00546	CbGpPWpGaD
Clemastine—Vision blurred—Cisplatin—esophageal cancer	0.00349	0.0138	CcSEcCtD
Clemastine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP19A1—esophageal cancer	0.00349	0.00539	CbGpPWpGaD
Clemastine—Tremor—Cisplatin—esophageal cancer	0.00347	0.0138	CcSEcCtD
Clemastine—CYP2D6—Oxidation by Cytochrome P450—CYP19A1—esophageal cancer	0.00344	0.00531	CbGpPWpGaD
Clemastine—Neuropathy peripheral—Capecitabine—esophageal cancer	0.00343	0.0136	CcSEcCtD
Clemastine—CYP3A4—Phase 1 - Functionalization of compounds—CYP26A1—esophageal cancer	0.00342	0.00529	CbGpPWpGaD
Clemastine—CYP2D6—Biological oxidations—ADH7—esophageal cancer	0.00341	0.00527	CbGpPWpGaD
Clemastine—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—esophageal cancer	0.0033	0.0051	CbGpPWpGaD
Clemastine—Agranulocytosis—Capecitabine—esophageal cancer	0.00326	0.0129	CcSEcCtD
Clemastine—Irritability—Methotrexate—esophageal cancer	0.00322	0.0128	CcSEcCtD
Clemastine—Convulsion—Cisplatin—esophageal cancer	0.00321	0.0127	CcSEcCtD
Clemastine—HRH1—GPCR ligand binding—ADCYAP1—esophageal cancer	0.00319	0.00492	CbGpPWpGaD
Clemastine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—GNG7—esophageal cancer	0.00317	0.00489	CbGpPWpGaD
Clemastine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—esophageal cancer	0.00315	0.00486	CbGpPWpGaD
Clemastine—Anaphylactic shock—Cisplatin—esophageal cancer	0.00302	0.012	CcSEcCtD
Clemastine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A6—esophageal cancer	0.00301	0.00465	CbGpPWpGaD
Clemastine—CYP2D6—Phase 1 - Functionalization of compounds—CYP1B1—esophageal cancer	0.00301	0.00464	CbGpPWpGaD
Clemastine—CYP3A4—Tryptophan metabolism—CYP1B1—esophageal cancer	0.003	0.00463	CbGpPWpGaD
Clemastine—CYP2D6—Biological oxidations—ADH1B—esophageal cancer	0.00299	0.00462	CbGpPWpGaD
Clemastine—CYP3A4—Oxidation by Cytochrome P450—CYP2A6—esophageal cancer	0.00297	0.00458	CbGpPWpGaD
Clemastine—Thrombocytopenia—Cisplatin—esophageal cancer	0.00296	0.0117	CcSEcCtD
Clemastine—Tachycardia—Cisplatin—esophageal cancer	0.00295	0.0117	CcSEcCtD
Clemastine—Tinnitus—Capecitabine—esophageal cancer	0.00293	0.0116	CcSEcCtD
Clemastine—Hyperhidrosis—Cisplatin—esophageal cancer	0.00292	0.0116	CcSEcCtD
Clemastine—HRH1—G alpha (q) signalling events—ANXA1—esophageal cancer	0.0029	0.00448	CbGpPWpGaD
Clemastine—Anorexia—Cisplatin—esophageal cancer	0.00288	0.0114	CcSEcCtD
Clemastine—CYP2D6—Phase 1 - Functionalization of compounds—CYP19A1—esophageal cancer	0.00283	0.00437	CbGpPWpGaD
Clemastine—Hypotension—Cisplatin—esophageal cancer	0.00283	0.0112	CcSEcCtD
Clemastine—CYP3A4—Tryptophan metabolism—CYP19A1—esophageal cancer	0.00282	0.00435	CbGpPWpGaD
Clemastine—Chills—Capecitabine—esophageal cancer	0.00282	0.0112	CcSEcCtD
Clemastine—CYP2D6—Biological oxidations—CYP26A1—esophageal cancer	0.00278	0.00429	CbGpPWpGaD
Clemastine—HRH1—G alpha (q) signalling events—GHRL—esophageal cancer	0.00275	0.00425	CbGpPWpGaD
Clemastine—CYP2D6—Metapathway biotransformation—CYP26A1—esophageal cancer	0.00274	0.00424	CbGpPWpGaD
Clemastine—Paraesthesia—Cisplatin—esophageal cancer	0.00272	0.0108	CcSEcCtD
Clemastine—Photosensitivity reaction—Methotrexate—esophageal cancer	0.00266	0.0106	CcSEcCtD
Clemastine—Decreased appetite—Cisplatin—esophageal cancer	0.00263	0.0104	CcSEcCtD
Clemastine—Drowsiness—Methotrexate—esophageal cancer	0.0026	0.0103	CcSEcCtD
Clemastine—CYP3A4—Phase 1 - Functionalization of compounds—ALDH2—esophageal cancer	0.0026	0.00401	CbGpPWpGaD
Clemastine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—ANXA1—esophageal cancer	0.00259	0.00401	CbGpPWpGaD
Clemastine—CYP2D6—Biological oxidations—GSTO1—esophageal cancer	0.00259	0.00399	CbGpPWpGaD
Clemastine—Vision blurred—Capecitabine—esophageal cancer	0.00257	0.0102	CcSEcCtD
Clemastine—Tremor—Capecitabine—esophageal cancer	0.00256	0.0101	CcSEcCtD
Clemastine—CYP2D6—Metapathway biotransformation—GSTO1—esophageal cancer	0.00255	0.00394	CbGpPWpGaD
Clemastine—HRH1—IL-4 Signaling Pathway—EP300—esophageal cancer	0.00255	0.00393	CbGpPWpGaD
Clemastine—Feeling abnormal—Cisplatin—esophageal cancer	0.00249	0.00988	CcSEcCtD
Clemastine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—GHRL—esophageal cancer	0.00246	0.0038	CbGpPWpGaD
Clemastine—Vertigo—Capecitabine—esophageal cancer	0.00245	0.00973	CcSEcCtD
Clemastine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A6—esophageal cancer	0.00244	0.00377	CbGpPWpGaD
Clemastine—Agranulocytosis—Methotrexate—esophageal cancer	0.00243	0.00963	CcSEcCtD
Clemastine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—esophageal cancer	0.00243	0.00374	CbGpPWpGaD
Clemastine—Palpitations—Capecitabine—esophageal cancer	0.00241	0.00957	CcSEcCtD
Clemastine—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—esophageal cancer	0.00239	0.0037	CbGpPWpGaD
Clemastine—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—esophageal cancer	0.00231	0.00357	CbGpPWpGaD
Clemastine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—esophageal cancer	0.00228	0.00352	CbGpPWpGaD
Clemastine—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—esophageal cancer	0.00225	0.00347	CbGpPWpGaD
Clemastine—Confusional state—Capecitabine—esophageal cancer	0.00225	0.00891	CcSEcCtD
Clemastine—CYP3A4—Biological oxidations—ADH7—esophageal cancer	0.00223	0.00344	CbGpPWpGaD
Clemastine—Thrombocytopenia—Capecitabine—esophageal cancer	0.00218	0.00865	CcSEcCtD
Clemastine—Tinnitus—Methotrexate—esophageal cancer	0.00218	0.00863	CcSEcCtD
Clemastine—Tachycardia—Capecitabine—esophageal cancer	0.00218	0.00863	CcSEcCtD
Clemastine—Asthenia—Cisplatin—esophageal cancer	0.00217	0.0086	CcSEcCtD
Clemastine—Hyperhidrosis—Capecitabine—esophageal cancer	0.00215	0.00854	CcSEcCtD
Clemastine—Anorexia—Capecitabine—esophageal cancer	0.00212	0.00843	CcSEcCtD
Clemastine—CYP2D6—Biological oxidations—ALDH2—esophageal cancer	0.00211	0.00325	CbGpPWpGaD
Clemastine—Chills—Methotrexate—esophageal cancer	0.0021	0.00831	CcSEcCtD
Clemastine—Hypotension—Capecitabine—esophageal cancer	0.00208	0.00826	CcSEcCtD
Clemastine—Diarrhoea—Cisplatin—esophageal cancer	0.00207	0.0082	CcSEcCtD
Clemastine—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL2—esophageal cancer	0.00207	0.00319	CbGpPWpGaD
Clemastine—Insomnia—Capecitabine—esophageal cancer	0.00202	0.00799	CcSEcCtD
Clemastine—CYP2D6—Biological oxidations—GSTT1—esophageal cancer	0.00201	0.0031	CbGpPWpGaD
Clemastine—Paraesthesia—Capecitabine—esophageal cancer	0.002	0.00794	CcSEcCtD
Clemastine—CYP2D6—Biological oxidations—CYP2A6—esophageal cancer	0.00198	0.00306	CbGpPWpGaD
Clemastine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—esophageal cancer	0.00197	0.00304	CbGpPWpGaD
Clemastine—Dyspepsia—Capecitabine—esophageal cancer	0.00196	0.00778	CcSEcCtD
Clemastine—CYP3A4—Biological oxidations—ADH1B—esophageal cancer	0.00196	0.00302	CbGpPWpGaD
Clemastine—Decreased appetite—Capecitabine—esophageal cancer	0.00194	0.00768	CcSEcCtD
Clemastine—Vomiting—Cisplatin—esophageal cancer	0.00192	0.00762	CcSEcCtD
Clemastine—Fatigue—Capecitabine—esophageal cancer	0.00192	0.00762	CcSEcCtD
Clemastine—HRH1—Class A/1 (Rhodopsin-like receptors)—ANXA1—esophageal cancer	0.00192	0.00297	CbGpPWpGaD
Clemastine—Vision blurred—Methotrexate—esophageal cancer	0.00192	0.0076	CcSEcCtD
Clemastine—Constipation—Capecitabine—esophageal cancer	0.00191	0.00756	CcSEcCtD
Clemastine—HRH1—IL-4 Signaling Pathway—PIK3CA—esophageal cancer	0.00188	0.00291	CbGpPWpGaD
Clemastine—CYP2D6—Biological oxidations—PTGS1—esophageal cancer	0.00188	0.0029	CbGpPWpGaD
Clemastine—HRH1—Class A/1 (Rhodopsin-like receptors)—SST—esophageal cancer	0.00187	0.00289	CbGpPWpGaD
Clemastine—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—esophageal cancer	0.00185	0.00285	CbGpPWpGaD
Clemastine—Feeling abnormal—Capecitabine—esophageal cancer	0.00184	0.00728	CcSEcCtD
Clemastine—Vertigo—Methotrexate—esophageal cancer	0.00183	0.00724	CcSEcCtD
Clemastine—HRH1—Class A/1 (Rhodopsin-like receptors)—GHRL—esophageal cancer	0.00182	0.00281	CbGpPWpGaD
Clemastine—CYP3A4—Biological oxidations—CYP26A1—esophageal cancer	0.00182	0.00281	CbGpPWpGaD
Clemastine—HRH1—GPCR downstream signaling—ADCYAP1—esophageal cancer	0.0018	0.00278	CbGpPWpGaD
Clemastine—Nausea—Cisplatin—esophageal cancer	0.0018	0.00712	CcSEcCtD
Clemastine—CYP3A4—Metapathway biotransformation—CYP26A1—esophageal cancer	0.00179	0.00277	CbGpPWpGaD
Clemastine—HRH1—GPCR ligand binding—GNG7—esophageal cancer	0.00179	0.00276	CbGpPWpGaD
Clemastine—Convulsion—Methotrexate—esophageal cancer	0.00176	0.00699	CcSEcCtD
Clemastine—CYP3A4—Biological oxidations—GSTO1—esophageal cancer	0.00169	0.00261	CbGpPWpGaD
Clemastine—Confusional state—Methotrexate—esophageal cancer	0.00167	0.00663	CcSEcCtD
Clemastine—CYP3A4—Metapathway biotransformation—GSTO1—esophageal cancer	0.00167	0.00257	CbGpPWpGaD
Clemastine—Anaphylactic shock—Methotrexate—esophageal cancer	0.00166	0.00658	CcSEcCtD
Clemastine—HRH1—Signaling by GPCR—ADCYAP1—esophageal cancer	0.00164	0.00252	CbGpPWpGaD
Clemastine—Thrombocytopenia—Methotrexate—esophageal cancer	0.00162	0.00644	CcSEcCtD
Clemastine—Hyperhidrosis—Methotrexate—esophageal cancer	0.0016	0.00636	CcSEcCtD
Clemastine—Asthenia—Capecitabine—esophageal cancer	0.0016	0.00634	CcSEcCtD
Clemastine—CYP2D6—Biological oxidations—CYP1B1—esophageal cancer	0.0016	0.00247	CbGpPWpGaD
Clemastine—Anorexia—Methotrexate—esophageal cancer	0.00158	0.00627	CcSEcCtD
Clemastine—CYP2D6—Metapathway biotransformation—CYP1B1—esophageal cancer	0.00158	0.00243	CbGpPWpGaD
Clemastine—HRH1—GPCR ligand binding—CXCL2—esophageal cancer	0.00157	0.00243	CbGpPWpGaD
Clemastine—Hypotension—Methotrexate—esophageal cancer	0.00155	0.00615	CcSEcCtD
Clemastine—Diarrhoea—Capecitabine—esophageal cancer	0.00153	0.00605	CcSEcCtD
Clemastine—CYP2D6—Biological oxidations—CYP19A1—esophageal cancer	0.0015	0.00232	CbGpPWpGaD
Clemastine—Insomnia—Methotrexate—esophageal cancer	0.0015	0.00595	CcSEcCtD
Clemastine—HRH1—Signaling Pathways—GDI2—esophageal cancer	0.0015	0.00231	CbGpPWpGaD
Clemastine—Paraesthesia—Methotrexate—esophageal cancer	0.00149	0.00591	CcSEcCtD
Clemastine—CYP2D6—Metapathway biotransformation—CYP19A1—esophageal cancer	0.00148	0.00229	CbGpPWpGaD
Clemastine—Somnolence—Methotrexate—esophageal cancer	0.00148	0.00585	CcSEcCtD
Clemastine—Dizziness—Capecitabine—esophageal cancer	0.00147	0.00584	CcSEcCtD
Clemastine—HRH1—GPCR ligand binding—ANXA1—esophageal cancer	0.00146	0.00226	CbGpPWpGaD
Clemastine—Dyspepsia—Methotrexate—esophageal cancer	0.00146	0.00579	CcSEcCtD
Clemastine—Decreased appetite—Methotrexate—esophageal cancer	0.00144	0.00572	CcSEcCtD
Clemastine—Fatigue—Methotrexate—esophageal cancer	0.00143	0.00567	CcSEcCtD
Clemastine—HRH1—GPCR ligand binding—SST—esophageal cancer	0.00142	0.0022	CbGpPWpGaD
Clemastine—Vomiting—Capecitabine—esophageal cancer	0.00142	0.00562	CcSEcCtD
Clemastine—Headache—Capecitabine—esophageal cancer	0.0014	0.00554	CcSEcCtD
Clemastine—HRH1—GPCR ligand binding—GHRL—esophageal cancer	0.00139	0.00214	CbGpPWpGaD
Clemastine—CYP3A4—Biological oxidations—ALDH2—esophageal cancer	0.00138	0.00213	CbGpPWpGaD
Clemastine—Feeling abnormal—Methotrexate—esophageal cancer	0.00137	0.00542	CcSEcCtD
Clemastine—Nausea—Capecitabine—esophageal cancer	0.00132	0.00525	CcSEcCtD
Clemastine—CYP3A4—Biological oxidations—GSTT1—esophageal cancer	0.00131	0.00202	CbGpPWpGaD
Clemastine—CYP3A4—Biological oxidations—CYP2A6—esophageal cancer	0.0013	0.002	CbGpPWpGaD
Clemastine—CYP3A4—Biological oxidations—PTGS1—esophageal cancer	0.00123	0.0019	CbGpPWpGaD
Clemastine—Asthenia—Methotrexate—esophageal cancer	0.00119	0.00472	CcSEcCtD
Clemastine—HRH1—GPCR downstream signaling—AKAP13—esophageal cancer	0.00116	0.00179	CbGpPWpGaD
Clemastine—Diarrhoea—Methotrexate—esophageal cancer	0.00114	0.0045	CcSEcCtD
Clemastine—Dizziness—Methotrexate—esophageal cancer	0.0011	0.00435	CcSEcCtD
Clemastine—HRH1—Signaling Pathways—KMT2D—esophageal cancer	0.00108	0.00167	CbGpPWpGaD
Clemastine—HRH1—GPCR downstream signaling—PDE4D—esophageal cancer	0.00106	0.00164	CbGpPWpGaD
Clemastine—Vomiting—Methotrexate—esophageal cancer	0.00106	0.00418	CcSEcCtD
Clemastine—HRH1—Signaling by GPCR—AKAP13—esophageal cancer	0.00105	0.00163	CbGpPWpGaD
Clemastine—CYP3A4—Biological oxidations—CYP1B1—esophageal cancer	0.00104	0.00161	CbGpPWpGaD
Clemastine—Headache—Methotrexate—esophageal cancer	0.00104	0.00412	CcSEcCtD
Clemastine—CYP3A4—Metapathway biotransformation—CYP1B1—esophageal cancer	0.00103	0.00159	CbGpPWpGaD
Clemastine—HRH1—GPCR downstream signaling—GNG7—esophageal cancer	0.00101	0.00156	CbGpPWpGaD
Clemastine—Nausea—Methotrexate—esophageal cancer	0.000986	0.00391	CcSEcCtD
Clemastine—CYP3A4—Biological oxidations—CYP19A1—esophageal cancer	0.000982	0.00152	CbGpPWpGaD
Clemastine—CYP3A4—Metapathway biotransformation—CYP19A1—esophageal cancer	0.000969	0.0015	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—ADCYAP1—esophageal cancer	0.000966	0.00149	CbGpPWpGaD
Clemastine—HRH1—Signaling by GPCR—PDE4D—esophageal cancer	0.000964	0.00149	CbGpPWpGaD
Clemastine—HRH1—Signaling by GPCR—GNG7—esophageal cancer	0.000917	0.00142	CbGpPWpGaD
Clemastine—HRH1—GPCR downstream signaling—CXCL2—esophageal cancer	0.000889	0.00137	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—WWOX—esophageal cancer	0.000884	0.00136	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—FKBP1A—esophageal cancer	0.00084	0.0013	CbGpPWpGaD
Clemastine—HRH1—GPCR downstream signaling—ANXA1—esophageal cancer	0.000827	0.00128	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—WIF1—esophageal cancer	0.000821	0.00127	CbGpPWpGaD
Clemastine—HRH1—Signaling by GPCR—CXCL2—esophageal cancer	0.000808	0.00125	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—BLVRB—esophageal cancer	0.000807	0.00125	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—SLC52A3—esophageal cancer	0.000807	0.00125	CbGpPWpGaD
Clemastine—HRH1—GPCR downstream signaling—SST—esophageal cancer	0.000804	0.00124	CbGpPWpGaD
Clemastine—HRH1—GPCR downstream signaling—GHRL—esophageal cancer	0.000784	0.00121	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—CSNK1A1—esophageal cancer	0.000758	0.00117	CbGpPWpGaD
Clemastine—HRH1—Signaling by GPCR—ANXA1—esophageal cancer	0.000751	0.00116	CbGpPWpGaD
Clemastine—HRH1—Signaling by GPCR—SST—esophageal cancer	0.00073	0.00113	CbGpPWpGaD
Clemastine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—esophageal cancer	0.000719	0.00111	CbGpPWpGaD
Clemastine—HRH1—Signaling by GPCR—GHRL—esophageal cancer	0.000712	0.0011	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—PFN1—esophageal cancer	0.000709	0.00109	CbGpPWpGaD
Clemastine—HRH1—G alpha (q) signalling events—PIK3CA—esophageal cancer	0.000698	0.00108	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—SLC10A2—esophageal cancer	0.000686	0.00106	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—CA1—esophageal cancer	0.000686	0.00106	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—ELMO1—esophageal cancer	0.000637	0.000983	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—CA2—esophageal cancer	0.000628	0.000969	CbGpPWpGaD
Clemastine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—esophageal cancer	0.000624	0.000963	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—AKAP13—esophageal cancer	0.000623	0.000961	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—PLCE1—esophageal cancer	0.000584	0.000901	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—ADH7—esophageal cancer	0.000584	0.000901	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—HIST1H2BM—esophageal cancer	0.000575	0.000887	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—PDE4D—esophageal cancer	0.000569	0.000879	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—GNG7—esophageal cancer	0.000542	0.000836	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—SLC52A3—esophageal cancer	0.000528	0.000815	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—BLVRB—esophageal cancer	0.000528	0.000815	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—ADH1B—esophageal cancer	0.000512	0.00079	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—XIAP—esophageal cancer	0.000507	0.000783	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—TYMP—esophageal cancer	0.000489	0.000755	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—CTNNA1—esophageal cancer	0.00048	0.000741	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—CXCL2—esophageal cancer	0.000477	0.000737	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—CYP26A1—esophageal cancer	0.000476	0.000734	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—ALOX15—esophageal cancer	0.000464	0.000716	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—CA1—esophageal cancer	0.000449	0.000693	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—SLC10A2—esophageal cancer	0.000449	0.000693	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—PSME2—esophageal cancer	0.000446	0.000688	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—PSME1—esophageal cancer	0.000446	0.000688	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—ANXA1—esophageal cancer	0.000444	0.000685	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—TPI1—esophageal cancer	0.000442	0.000683	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—GSTO1—esophageal cancer	0.000442	0.000683	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—SST—esophageal cancer	0.000431	0.000666	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—ALDOB—esophageal cancer	0.000424	0.000655	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—GHRL—esophageal cancer	0.000421	0.000649	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—NOTCH3—esophageal cancer	0.000421	0.000649	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—FBXW7—esophageal cancer	0.000414	0.000639	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—CA2—esophageal cancer	0.00041	0.000634	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—GAPDH—esophageal cancer	0.000408	0.00063	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—CRABP1—esophageal cancer	0.000405	0.000624	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—GNG7—esophageal cancer	0.000385	0.000594	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—ADH7—esophageal cancer	0.000382	0.000589	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—PLCE1—esophageal cancer	0.000382	0.000589	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—NOTCH2—esophageal cancer	0.000377	0.000582	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—ALDH2—esophageal cancer	0.000361	0.000557	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—GSTT1—esophageal cancer	0.000343	0.000529	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—CYP2A6—esophageal cancer	0.000339	0.000523	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—ADH1B—esophageal cancer	0.000335	0.000516	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—TGFBR2—esophageal cancer	0.000335	0.000516	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—ENO1—esophageal cancer	0.000321	0.000496	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—PTGS1—esophageal cancer	0.000321	0.000496	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—TYMP—esophageal cancer	0.00032	0.000494	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—SMAD4—esophageal cancer	0.000317	0.000489	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—PSME1—esophageal cancer	0.000317	0.000489	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—PSME2—esophageal cancer	0.000317	0.000489	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—CYP26A1—esophageal cancer	0.000311	0.00048	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—ALOX15—esophageal cancer	0.000303	0.000468	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—GSTO1—esophageal cancer	0.000289	0.000446	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—TPI1—esophageal cancer	0.000289	0.000446	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—ALDOB—esophageal cancer	0.000277	0.000428	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—CYP1B1—esophageal cancer	0.000273	0.000422	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—GAPDH—esophageal cancer	0.000267	0.000412	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—CRABP1—esophageal cancer	0.000264	0.000408	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—HIF1A—esophageal cancer	0.000259	0.0004	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—CYP19A1—esophageal cancer	0.000257	0.000397	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—GNG7—esophageal cancer	0.000252	0.000388	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—KDR—esophageal cancer	0.000248	0.000383	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—ALDH2—esophageal cancer	0.000236	0.000364	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—HMOX1—esophageal cancer	0.000234	0.000362	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—NOTCH1—esophageal cancer	0.000233	0.00036	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—ABCB1—esophageal cancer	0.000225	0.000347	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—GSTT1—esophageal cancer	0.000224	0.000346	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—CYP2A6—esophageal cancer	0.000222	0.000342	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—CREBBP—esophageal cancer	0.000212	0.000327	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—ENO1—esophageal cancer	0.00021	0.000324	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—PTGS1—esophageal cancer	0.00021	0.000324	CbGpPWpGaD
Clemastine—HRH1—Signaling by GPCR—EGFR—esophageal cancer	0.000208	0.000321	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—PSME2—esophageal cancer	0.000207	0.00032	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—PSME1—esophageal cancer	0.000207	0.00032	CbGpPWpGaD
Clemastine—HRH1—GPCR downstream signaling—PIK3CA—esophageal cancer	0.000199	0.000307	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—NOS3—esophageal cancer	0.00019	0.000293	CbGpPWpGaD
Clemastine—HRH1—Signaling by GPCR—PIK3CA—esophageal cancer	0.000181	0.000279	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—CYP1B1—esophageal cancer	0.000179	0.000276	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—ERBB2—esophageal cancer	0.000177	0.000274	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—CYP19A1—esophageal cancer	0.000168	0.000259	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—CCND1—esophageal cancer	0.000157	0.000242	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—HMOX1—esophageal cancer	0.000153	0.000237	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—CDKN1A—esophageal cancer	0.000152	0.000234	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—CREBBP—esophageal cancer	0.00015	0.000232	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—ABCB1—esophageal cancer	0.000147	0.000227	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—EP300—esophageal cancer	0.000144	0.000223	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—NOS3—esophageal cancer	0.000135	0.000208	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—MYC—esophageal cancer	0.000126	0.000194	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—PTGS2—esophageal cancer	0.000123	0.00019	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—EGFR—esophageal cancer	0.000123	0.00019	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—PIK3CA—esophageal cancer	0.000107	0.000165	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—TP53—esophageal cancer	0.000103	0.000159	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—EP300—esophageal cancer	0.000102	0.000158	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—CREBBP—esophageal cancer	9.83e-05	0.000152	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—NOS3—esophageal cancer	8.8e-05	0.000136	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—PTGS2—esophageal cancer	8.05e-05	0.000124	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—PIK3CA—esophageal cancer	7.58e-05	0.000117	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—EP300—esophageal cancer	6.7e-05	0.000103	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—PIK3CA—esophageal cancer	4.95e-05	7.65e-05	CbGpPWpGaD
